Mainline agrees dry eye deal with InMode

Mainline Instruments will distribute the Envision suite of dry eye treatments in the UK after it signed an agreement with InMode. 

The Envision platform features non-surgical dry eye treatments that focusdelicate subdermal layers in the periorbital area; including Lumecca-I intense pulsed light; Forma-I thermal bipolar radiofrequency and Morpheus8 fractional skin treatment to stimulate the underlying layers of the dermis. 

Jack Hawkins, managing director of Mainline Instruments, commented: ‘As awareness of dry eye increases, more of our customers are seeking advanced treatments beyond traditional drops and wipes. Partnering with InMode enables us to provide the Envision platform, a state-of-the-art solution to meet the growing demand for effective dry eye care.’